Cargando…

Perceived barriers to methadone maintenance treatment among Iranian opioid users

BACKGROUND: Opioid use is a severe problem in Iran. Despite methadone maintenance treatment (MMT) programs being one of the most important treatment strategies for reducing individual and public harms associated with opioid use, a large proportion of Iranian patients refuse to participate in such tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Khazaee-Pool, Maryam, Moeeni, Maryam, Ponnet, Koen, Fallahi, Arezoo, Jahangiri, Leila, Pashaei, Tahereh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996552/
https://www.ncbi.nlm.nih.gov/pubmed/29890990
http://dx.doi.org/10.1186/s12939-018-0787-z
_version_ 1783330889356279808
author Khazaee-Pool, Maryam
Moeeni, Maryam
Ponnet, Koen
Fallahi, Arezoo
Jahangiri, Leila
Pashaei, Tahereh
author_facet Khazaee-Pool, Maryam
Moeeni, Maryam
Ponnet, Koen
Fallahi, Arezoo
Jahangiri, Leila
Pashaei, Tahereh
author_sort Khazaee-Pool, Maryam
collection PubMed
description BACKGROUND: Opioid use is a severe problem in Iran. Despite methadone maintenance treatment (MMT) programs being one of the most important treatment strategies for reducing individual and public harms associated with opioid use, a large proportion of Iranian patients refuse to participate in such treatment programs. METHODS: The present study aims to explore the beliefs and attitudes toward MMT programs of opioid-dependent patients who were participating or had participated in methadone therapy. In-depth interviews were conducted with 23 opioid users between 27 and 58 years of age from Kurdistan provinces. RESULTS: Overall, six themes were discovered to be key barriers relating to methadone treatment, including financial barriers related to methadone treatment, lack of awareness about methadone treatment, negative attitudes regarding using methadone, worries about methadone’s side effects, social stigma ascribed to methadone therapy, and systemic barriers to methadone treatment. CONCLUSION: Our study revealed that the cost of treatment is a major obstacle to attending and continuing at MMT programs and that addicts and their families are not always accurately informed about the duration of MMT programs and the side effects of methadone treatment.
format Online
Article
Text
id pubmed-5996552
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59965522018-06-25 Perceived barriers to methadone maintenance treatment among Iranian opioid users Khazaee-Pool, Maryam Moeeni, Maryam Ponnet, Koen Fallahi, Arezoo Jahangiri, Leila Pashaei, Tahereh Int J Equity Health Research BACKGROUND: Opioid use is a severe problem in Iran. Despite methadone maintenance treatment (MMT) programs being one of the most important treatment strategies for reducing individual and public harms associated with opioid use, a large proportion of Iranian patients refuse to participate in such treatment programs. METHODS: The present study aims to explore the beliefs and attitudes toward MMT programs of opioid-dependent patients who were participating or had participated in methadone therapy. In-depth interviews were conducted with 23 opioid users between 27 and 58 years of age from Kurdistan provinces. RESULTS: Overall, six themes were discovered to be key barriers relating to methadone treatment, including financial barriers related to methadone treatment, lack of awareness about methadone treatment, negative attitudes regarding using methadone, worries about methadone’s side effects, social stigma ascribed to methadone therapy, and systemic barriers to methadone treatment. CONCLUSION: Our study revealed that the cost of treatment is a major obstacle to attending and continuing at MMT programs and that addicts and their families are not always accurately informed about the duration of MMT programs and the side effects of methadone treatment. BioMed Central 2018-06-11 /pmc/articles/PMC5996552/ /pubmed/29890990 http://dx.doi.org/10.1186/s12939-018-0787-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Khazaee-Pool, Maryam
Moeeni, Maryam
Ponnet, Koen
Fallahi, Arezoo
Jahangiri, Leila
Pashaei, Tahereh
Perceived barriers to methadone maintenance treatment among Iranian opioid users
title Perceived barriers to methadone maintenance treatment among Iranian opioid users
title_full Perceived barriers to methadone maintenance treatment among Iranian opioid users
title_fullStr Perceived barriers to methadone maintenance treatment among Iranian opioid users
title_full_unstemmed Perceived barriers to methadone maintenance treatment among Iranian opioid users
title_short Perceived barriers to methadone maintenance treatment among Iranian opioid users
title_sort perceived barriers to methadone maintenance treatment among iranian opioid users
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996552/
https://www.ncbi.nlm.nih.gov/pubmed/29890990
http://dx.doi.org/10.1186/s12939-018-0787-z
work_keys_str_mv AT khazaeepoolmaryam perceivedbarrierstomethadonemaintenancetreatmentamongiranianopioidusers
AT moeenimaryam perceivedbarrierstomethadonemaintenancetreatmentamongiranianopioidusers
AT ponnetkoen perceivedbarrierstomethadonemaintenancetreatmentamongiranianopioidusers
AT fallahiarezoo perceivedbarrierstomethadonemaintenancetreatmentamongiranianopioidusers
AT jahangirileila perceivedbarrierstomethadonemaintenancetreatmentamongiranianopioidusers
AT pashaeitahereh perceivedbarrierstomethadonemaintenancetreatmentamongiranianopioidusers